| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |